Cart
0
Orders
Kairax product image

Kairax

Compare Kairax FINE, DEEP and SUB Q fillers: 24 mg/mL cross-linked sodium hyaluronate, 0.3% lidocaine hydrochloride and 1 mL syringe specifications.
★0(0)
Main Composition
Cross-Linked Sodium Hyaluronate 24 mg/mL, Lidocaine Hydrochloride 0.3%
Country of Origin
South Korea

Product Range


Kairax
FINE
$ 38
1.0 mL
1 Syringe / 1 Box
Not available here
i
Preparing To Sale
Kairax
DEEP
$ 38
1.0 mL
1 Syringe / 1 Box
Not available here
i
Preparing To Sale
Kairax
SUB Q
$ 38
1.0 mL
1 Syringe / 1 Box
Not available here
i
Preparing To Sale

Suggested Collaboration


Details about Kairax


Product Overview

Kairax FINE is a cross-linked hyaluronic acid dermal filler containing lidocaine, presented here alongside Kairax DEEP and Kairax SUB Q. The documented 1 mL formulations contain cross-linked sodium hyaluronate at 24 mg/mL and lidocaine hydrochloride at 0.3%. This comparison helps professional buyers distinguish the three named formulations and their documented packaging. It covers the 1 mL lidocaine versions; the exact formulation, accessories and market-specific labeling should be checked against the supplied carton before procurement.

Key Features

  • Cross-linked HA: The documented FINE formulation contains 24 mg/mL of cross-linked sodium hyaluronate.
  • Lidocaine-containing formulation: The published concentration is 0.3% on a lidocaine hydrochloride basis.
  • 1 mL presentation: The documented UK presentation contains one prefilled syringe per box.

Kairax FINE Composition & Specifications

SpecificationKairax FINE
Product categoryCross-linked hyaluronic acid dermal filler with lidocaine
Principal HA ingredientCross-linked sodium hyaluronate, 24 mg/mL
Lidocaine contentLidocaine hydrochloride, 0.3%
Syringe volume1 mL
Documented UK packOne prefilled syringe and two 30G needles per box
Country of manufactureSouth Korea

These specifications describe the documented 1 mL lidocaine formulation. Regional packaging information does not confirm the accessories included with every supplied lot.

Kairax FINE, DEEP & SUB Q Comparison

Each named 1 mL formulation is separately documented with cross-linked sodium hyaluronate at 24 mg/mL and lidocaine hydrochloride at 0.3%. The UK presentations each contain one prefilled syringe and two needles, with the needle gauge differing as shown below. Catalog SKUs identify TEOSQUARE options; they are not manufacturer reference numbers.

FormulationTEOSQUARE catalog SKUSyringe volumeNeedles in documented UK pack
Kairax FINEkairax-fine1 mLTwo 30G needles
Kairax DEEPkairax-deep1 mLTwo 27G needles
Kairax SUB Qkairax-subq1 mLTwo 25G needles

Accessory differences are packaging specifications, not treatment recommendations. Shared ingredient concentrations should not be used to infer interchangeable clinical performance.

Frequently Asked Questions

Does this Kairax FINE description cover a lidocaine-free version?

No. This description covers the documented 1 mL formulation containing lidocaine hydrochloride at 0.3%. Check the exact product label rather than assuming that similarly named listings describe the same formulation.

What should professional buyers check before procurement?

Match the formulation name, syringe volume, manufacturer identification and pack contents to the supplied carton and instructions for use. Confirm destination-market authorization and purchasing eligibility separately; this comparison does not establish permission to import, purchase or use the product in a particular country.

Reviews

★0(0)

Loading reviews...